Skip to content

Effect of Music in Reducing Pain and Anxiety During Hysterosalpingography in Women With Primary Infertility

Effect of Music in Reducing Pain and Anxiety During Hysterosalpingography in Women With Primary Infertility: a Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06772636
Enrollment
110
Registered
2025-01-13
Start date
2025-03-01
Completion date
2025-08-20
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

This study aims to demonstrate the value of music in lowering pain and anxiety during hysterosalpingography in women with primary infertility

Detailed description

This study aims to demonstrate the value of music in lowering pain and anxiety during hysterosalpingography in women with primary infertility

Interventions

PROCEDUREmusic group

In the music group, the music chosen by the participant will be played through a speaker by the nursing staff during outpatient hysteroscopy. Music will be played through a speaker instead of headphones in order to maintain good communication and interaction between the participant and the doctor.

Participants in the non-music group will undergo hysterosalpingography in the same setting and standard procedure without listening to any music.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Women aged 18-45 years. Diagnosed with primary infertility (no prior pregnancy after at least 12 months of unprotected intercourse) and scheduled for HSG as part of infertility evaluation.

Exclusion criteria

* Using analgesics before or after the procedure, using antidepressants or sedative medications, being allergic to radio-opaque material, Current pregnancy or suspicion of pregnancy.Active pelvic inflammatory disease or history of severe pelvic infections within the last 6 months.

Design outcomes

Primary

MeasureTime frameDescription
Intensity of pain10 minutesPain intensity will be assessed by visual analog scale during the procedure. visual analog scale ranging from 0 to 10 where 0 denotes no pain and 10 denotes maximum pain felt

Secondary

MeasureTime frameDescription
anxiety during procedure10 minutesanxiety will be measured using 10 cm VAS like score where 0 denotes no anxiety and 10 represents maximum anxiety

Contacts

Primary ContactAHMED SAMY ALI ASHOUR, MD
ahmedsamy8233@gmail.com01100681167

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026